Cited by 13Frailty in Older AdultsNutrition and Health in AgingPharmaceutical Practices and Patient Outcomes

Pharmacological treatment of frailty in the elderly

Campbell, Stephen, Szoeke, Cassandra·2009·Journal of Pharmacy Practice and Research

Abstract

The geriatric frailty syndrome can be characterised by a loss of physiological reserve in a variety of organ systems and an independent association with disability and mortality. The high cost of this condition in terms of decreased quality of life and an increased need for medical and personal care makes it an important focus for the development of effective pharmacological treatments. Several of these treatments have been trialled and have focused on the decreased levels of catabolic hormones seen in advancing age. Despite some improvement in muscle and tissue bulk, most of these treatments have failed to improve physical function in the elderly. In this review we examine the evidence for the pharmacological treatment of frailty in the elderly and provide recommendations for its management.

Integrity signals

Registry

Crossref · 10.1002/j.2055-2335.2009.tb00440.x

Cites

71 of 71 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Although frail older adults' muscles seem able to respond to IGF-1, supplementation trials in older people have not shown benefit.

    “although the muscles of frail older people appear to retain the capability to respond to IGF-1 (42) trials of IGF-1 supplementation in older people have failed to demonstrate benefit (43).”

    From Frailty in elderly people (2013) · cites this paper as [43]

  • The general use of vitamin D as treatment for frailty remains controversial.

    “the general use of vitamin D as treatment for frailty remains controversial (43).”

    From Frailty in elderly people (2013) · cites this paper as [43]

Cites

Flagged first, then by citations

2 of the 73 references couldn’t be matched to a known paper.

Cited by

Sorted by citations

Authors
Campbell, S., & Szoeke, C.
Affiliations
  • Austin Health (AU)
  • Commonwealth Scientific and Industrial Research Organisation (AU)
Venue
Journal of Pharmacy Practice and Research
Publisher
Wiley
Published
2009-06
Volume
39
Issue
2
Pages
147-151
ISSN
  • 0310-6810 (ISSN-L)
  • 1445-937X
  • 2055-2335
OpenAlex
W2141668666
Cited by
13
References
73
Citations by year
2026: 1 · 2024: 1 · 2020: 1 · 2019: 3 · 2018: 1 · 2017: 3 · 2014: 2 · 2013: 1
FWCI
0.00
Type
journal article
Language
en
Open access
closed
Locations
Journal of Pharmacy Practice and Research (publishedVersion)
Topics
  • Health Sciences › Medicine › Geriatrics and Gerontology › Frailty in Older Adults
  • Health Sciences › Medicine › Physiology › Nutrition and Health in Aging
  • Health Sciences › Medicine › Geriatrics and Gerontology › Pharmaceutical Practices and Patient Outcomes
Keywords
frailty, pharmacotherapy, older adults, geriatric syndromes, physiological reserve, catabolic hormones, muscle mass, physical function, disability, mortality, quality of life

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review